• Both Covaxin and Covishield (Oxford-AstraZeneca make) are developed in India. Hence, they may be termed relatively safer than other modern vaccines, and carry a lower than usual risk of side effects. Clinical studies have also proved that Indian vaccines have good efficacy rates right now.

  • Covaxin is effective against the UK and Brazilian variants while Covishield is effective against UK variants and is being tested against the Brazilian variant.